Lepu Scientech Medical

As a pioneer specializing in interventional medical devices targeting structural heart diseases and a large China-based supplier of CHD occluders and related procedural accessories, we are committed to providing safe, effective and innovative medical solutions. We are engaged in the research and development, manufacturing and marketing of interventional medical devices targeting structural heart diseases. With 50 products available on the market and under development, our product line covers CHD occluders for the interventional treatment of CHDs, LAA occluders and PFO occluders for the prevention and treatment of cardioembolic stroke, and interventional valves; hence, all-round solutions are available for the interventional therapy of structural heart diseases. Our products were sold overseas to 44 countries and regions in Asia, Europe, America and Africa. We are a strong player in research and development, with a number of innovative products with independent intellectual property rights, taking the lead in the research and development of biodegradable technologies. In 2009, the project of "development and clinical application of interventional treatment series occluder for defective congenital heart" was awarded “Second Prize of National Science and Technology Progress Award". As of April 26, 2023, the Company has been granted 234 registered patents. We will keep on investing in research and development, and developing novel products and technologies to benefit more patients with structural heart diseases, thereby contributing to the cause of human health.